Point72 Asset Management »

Zenas Biopharma shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $975k 58k 16.92

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Shell Spon Ads (SHEL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Arista Networks (ANET)
Comcast Corp Cl A (CMCSA)
Boston Scientific Corporation (BSX)
M/a (MTSI)
Lumentum Hldgs (LITE)
Intuitive Surgical Com New (ISRG)
Alphabet Cap Stk Cl A (GOOGL)
ConocoPhillips (COP)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Zenas Biopharma

NEA Management Company
Fairmount Funds Management
NVP Associates
Deerfield Management Company
Federated Investors
Novo A/S
Perceptive Advisors
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Arrowpoint Asset Management
Monashee Investment Management
Citadel Advisors
Standard Life Aberdeen
Point72 Asset Management
Soros Fund Management

View all funds holding Zenas Biopharma